EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania

Samoel A Khamadi, Emmanuel Bahemana, Nicole Dear, Caroline Mavere, Fredy George, Razack Kapene, Grace Papianus, Walidah Willoughby, Jillian Chambers, Kavitha Ganesan, Iman Mwakabanje, Jason M Bacha und 8 weitere

Journal of the Pediatric Infectious Diseases Society · 30.06.2023 · 12 (6) · 353-363

DOI: 10.1093/jpids/piad040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 03.06.2023. Verfasst von Samoel A Khamadi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Walter Reed Program/HJF Medical Research International, Mbeya, Tanzania. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Achieving viral suppression (VS) for persons living with HIV is key to reaching epidemic control. We assessed the prevalence of VS and the frequency of HIV drug resistance mutations (HIVDRM) among children and adolescents living with HIV (CALHIV) in the Southern Highland zone of Tanzania.

Methods

From 2019 to 2021, we enrolled CALHIV aged 1–19 years on ART for >6 months in a cross-sectional study. Participants had viral load (VL) testing; those with VL ≥ 1000 copies/mL underwent HIVDRM testing. VS (<1000 copies/mL) prevalence estimates were calculated and robust Poisson regression was used to estimate prevalence ratios (PRs) and 95% confidence intervals (CIs) for associations with potential predictors of VS.

Results

Of 707 participants, 595 had VS (PR: 0.84, 95% CI: 0.81–0.87). Use of an integrase strand transfer inhibitor-containing regimen (aPR 1.15, 95% CI: 0.99–1.34), age 5–9 years (aPR 1.16, 95% CI: 1.07–1.26), and seeking care at a referral center (aPR 1.12, 95% CI: 1.04–1.21) were associated with VS. Factors inversely associated with VS included having one (aPR 0.82, 95% CI: 0.72–0.92) or two or more (aPR 0.79, 95% CI: 0.66–0.94) referrals for adherence counselling, and self-reporting missing one to two (aPR 0.88, 95% CI: 0.78–0.99) or three or more (aPR 0.77, 95% CI: 0.63–0.92) doses of ART in the past month. Of 74 participants with PRRT and INT sequencing done, 60 (81.1%) had HIVDRMs at the following frequencies: 71.6%, 67.6%, 1.4%, and 4.1% for major NNRTI, NRTI, PI, and INSTI respectively.

Conclusions

Higher rates of VS were observed in this cohort, and HIVDRMs were common in those without VS. This evidence supports ART optimization using dolutegravir-based regimens. However, better strategies to improve adherence are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsHumansChildAdolescentHIVTanzaniaCross-Sectional StudiesViral Load

Stichwörter der Autor:innen

children and adolescentsdrug resistanceintegrase inhibitorsviral suppression

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Walter Reed Program/HJF Medical Research International, Mbeya, Tanzania.
  • U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
  • Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Baylor College of Medicine, Department of Pediatrics, Houston, Texas, USA.
  • Baylor College of Medicine International Pediatric AIDS Initiative (BIPAI) at Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Baylor College of Medicine Children's Foundation-Tanzania, Mbeya, Tanzania.

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • U.S. Department of Defense
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Khamadi, S. A., Bahemana, E., Dear, N., Mavere, C., George, F., Kapene, R., Papianus, G., Willoughby, W., Chambers, J., Ganesan, K., Mwakabanje, I., Bacha, J. M., Desai, P., Almas, S., Coakley, P. D., Wolfman, V., Lee, E. H., Hickey, P. W., Livezey, J., & Agaba, P. A. (2023). Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania. Journal of the Pediatric Infectious Diseases Society, 12(6), 353-363. https://doi.org/10.1093/jpids/piad040

Vancouver

Khamadi SA, Bahemana E, Dear N, Mavere C, George F, Kapene R, et al. Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania. Journal of the Pediatric Infectious Diseases Society. 2023;12(6):353-363. doi:10.1093/jpids/piad040

BibTeX
@article{Khamadi2023,
  author = {Khamadi, Samoel A and Bahemana, Emmanuel and Dear, Nicole and Mavere, Caroline and George, Fredy and Kapene, Razack and Papianus, Grace and Willoughby, Walidah and Chambers, Jillian and Ganesan, Kavitha and Mwakabanje, Iman and Bacha, Jason M and Desai, Priyanka and Almas, Shaban and Coakley, Peter D and Wolfman, Vanessa and Lee, Elizabeth H and Hickey, Patrick W and Livezey, Jeffrey and Agaba, Patricia A},
  title = {Factors Associated With Viral Suppression and Drug Resistance in Children and Adolescents Living With HIV in Care and Treatment Programs in Southern Tanzania},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {353--363},
  doi = {10.1093/jpids/piad040}
}
Kostenlos starten →